Purpose

This study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be randomized 1:1 to one of two arms: time-restricted eating or control. Those in the intervention arm will self-select a 10-hour eating window in which to consume all food and beverages (water is allowed any time, black coffee and unsweetened tea are allowed in the morning). Both groups will receive weekly educational tips on healthy lifestyle behaviors in cancer survivorship. This study will also explore relationships between fatigue, circadian rhythm, and glucose metabolism. The hypothesis is that recruitment will be feasible, and participants will adhere to time-restricted eating and complete study activities over the course of the 12 weeks. The second hypothesis is that time-restricted eating will lead to less fatigue at 12 weeks compared to the control, accounting for baseline fatigue levels.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Have completed adjuvant chemotherapy, surgery, and/or radiation for cancer, including chemotherapy for hematologic neoplasms, at least 2 months and not more than 2 years prior to enrolling, - Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, "In the last week, how bad was your worst fatigue on a scale from 0-10?" - Be able to speak and/or read and write in English, - Be at least 18 years old, - Own a smartphone, - Be willing and able to adhere to study procedures, including use of a smartphone app, and - Be able to provide informed consent.

Exclusion Criteria

  • Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week, - Be underweight, as defined as a body mass index ≤18.5 kg/m2, - Have surgery planned during the study duration, - Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., type 1 diabetes, risk for hypoglycemia, medication requirements, pregnancy, breastfeeding, recent history of an eating disorder), - Be taking insulin, or - Be on enteral or parenteral nutrition.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Time-restricted eating
Participants will self-select a 10-hour window in which to consume all food and beverages (with the exception of black coffee and unsweetened tea in the mornings; water is okay at all times). Participants will also receive weekly tips to encourage a healthy lifestyle in cancer survivorship.
  • Behavioral: Time-restricted eating
    12 weeks of time-restricted eating (10-hour window)
  • Behavioral: Healthy lifestyle education
    Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
Other
Control
Participants will receive weekly tips to encourage healthy lifestyle behaviors in cancer survivorship.
  • Behavioral: Healthy lifestyle education
    Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks

Recruiting Locations

University of Maryland, Baltimore
Baltimore, Maryland 21201
Contact:
Amber Kleckner, PhD
410-706-5961
amber.kleckner@umaryland.edu

More Details

Status
Recruiting
Sponsor
University of Maryland, Baltimore

Study Contact

Amber Kleckner, PhD
4107065961
amber.kleckner@umaryland.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.